AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
10 862 GBX
-0.15%
Market Closed
Updated:
Apr 18, 2024
AstraZeneca PLC
Cash from Operating Activities
Last
Value
3-Years CAGR
5-Years CAGR
|
AstraZeneca PLC
Cash from Operating Activities Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Operating Activities
$10.3B
|
CAGR 3-Years
29%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Operating Activities
£6.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Cash from Operating Activities
$-50.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Operating Activities
$-315m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Operating Activities
$608m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Operating Activities
£63.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
See Also
What is AstraZeneca PLC's Cash from Operating Activities?
Cash from Operating Activities
10.3B
USD
10.3B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Cash from Operating Activities amounts to 10.3B USD.
What is AstraZeneca PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
3%
3%
Over the last year, the Cash from Operating Activities growth was 5%. The average annual Cash from Operating Activities growth rates for AstraZeneca PLC have been 29% over the past three years , 32% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
